The first three quarters of this year, China's foreign trade stable development

Pharmaceutical Network November 10 hearing the first three quarters of this year, China's import and export of traditional Chinese medicine 3.71 billion US dollars, an increase of 7.40%, of which 2.6 billion US dollars exports, down 0.27% year-on-year; imports 1.116 billion US dollars, up 30.81% year on year.

Among the commodities exports, Chinese Herbal Pieces showed more eye-catching export performance, with a significant increase of 49.68% in export volume but a slight increase in export value. Export performance has been very good for plant extracts with a slight decrease year-on-year year on year Big.

In the first three quarters, China's traditional Chinese medicines were exported to 118 countries and regions, of which the Asian region is both a traditional market and a major market for Chinese traditional medicine exports: the first three quarters of exports to Asian countries and regions were 1.5 billion U.S. dollars, down 0.06% , Accounting for 57.73%.

The United States used to be the second or third largest market for Chinese medicine exports and maintained a relatively high growth rate in the past two years. In the first three quarters of 2017, the United States surpassed Japan to overtake Japan's largest export market for Chinese medicine. The first three quarters Its exports to the United States reached 425 million U.S. dollars, accounting for 16.36% of the total exports of Chinese medicine. The exports of raw materials of Chinese herbal medicines and health products increased greatly year on year.

The first three quarters of China's exports to the Japanese market, medicine, an increase of 36.40%, exports 370 million US dollars, up slightly by 3.35%. Japan's exports are mainly plant extracts and Chinese herbal medicine Pieces, including plant extracts in terms of quantity Or the amount of exports have a certain increase over the same period last year.

China's Hong Kong continued to be the third largest market for mainland Chinese medicine exports, with exports of 340 million U.S. dollars in the first three quarters, down 15.30% over the same period of last year.

The first three quarters of China's exports of Korean medicine to 150 million US dollars, down 13.47%, accounting for 5.85% of China's exports of Chinese medicine exports to South Korea are mainly plant extracts and Chinese herbal medicines Pieces, the two exports amounted to 73,394,500 US dollars, Down 20.63% from a year earlier.

China exported 444 million U.S. dollars of Chinese medicine to Europe in the first three quarters, down slightly by 1.66% year-on-year, accounting for 17.10% of the total exports of Chinese medicine. The main plant extracts from Europe accounted for 71.99% of the total exports of Chinese medicine. The major export markets are Germany Spain and France.

The EU is one of the largest botanical drug markets in the world and one of the major target markets for the export of proprietary Chinese medicines in recent years. The registration of traditional Chinese medicines in the EU is a hot topic in the Chinese medicine industry in recent years, drug As a result, China's exports of proprietary Chinese medicines to the EU have shown a downward trend since the implementation of Directive 2004/24 / EC, but in the first three quarters of this year, China's exports to the former EU ten The exports of proprietary Chinese medicines from the five countries reached US $ 5,005,300, an increase of 8.73% over the same period of last year, while the exports to the EU with a total of 12 countries eastward expanded by 3.5596 million US dollars, up 3.59% from the same period of last year.

With regard to various varieties and plant extracts, the United States has replaced Japan as the largest export market of plant extracts in China since 2011. The US plant extracts are mainly used for the production of dietary supplements and food additives, and the demand has been relatively strong. China's exports of plant extracts to Japan, mainly for Japanese Kampo ingredients. Plant extracts exported to South Korea is mainly used as Health products with cosmetic raw material.

Main Mainland exports to Hong Kong Medicinal herbs Noteworthy is that Hong Kong has also been the main export market of Cordyceps sinensis, but with the export prices continue to rise, Cordyceps sharp decline in exports to Hong Kong, Cordyceps in 2013 export price reached 29348.34 US dollars / Kg, an increase of 16.07% over the same period of last year, and the export volume shrank to 305kg, down 57.7% from a year earlier. By 2015, the mainland's cordyceps exports to Hong Kong have rebounded and the export prices have been relatively stable. In the first three quarters of this year, For 469 kilograms, export price is 22,506.55 dollars / kilogram, grow 18.56% compared to the same period.

China's exports of health products have been mainly raw materials, the lack of high value-added health care products. The United States and Japan have been the main market for the export of health products in China, of which more than 55% of China's exports of health products are fish oil products; Exports of health care products to Japan are mainly royal jelly products, accounting for about 90% of China's health products exports to Japan in recent years, China's Royal Jelly International standard The formulation of the work has made breakthrough progress and promoted the development of our royal jelly industry, quality supervision and scientific research so that our country's international price dominance in this field will be enhanced.

In the first three quarters of 2017, the import volume of China's bird's nest was 48,341 kg, up 84.89% over the same period of last year, while the import price was US $ 1,683.43 / kg, up 12.88% over the same period of last year. The reason for the surge in imports was mainly the consumption of domestic bird's nest products, 2017 China New Year big data report ", bird's nest in the Hot Local Products ranked fifth.

In the first three quarters of 2017, the import of antler in our country was 485,861 kg, an increase of 22.88% over the same period of last year. The import price was 58.63 USD / kg, up by 221.30% over the same period of last year. Import of 98.30% of China's antler was from New Zealand.

In the first three quarters of 2017, China's ginseng exports were 1,177,909 kg, down 18.36% from the same period of last year while the export price was 50.04 USD / kg, down 31.87% from the same period of last year. The main reason for the decline in exports of ginseng in China was the weaker demand in Japan and Europe.